PERP, an apoptosis-associated target of p53, in a novel member of the PMP-22/gas3 family

Genes and Development

Volumn 14, Issue 6, 2000, Pages 704-718

  Attardi, Laura D ^a   Reczek, Elizabeth E ^a   Cosmas, Corinna ^a   Demicco, Elizabeth G ^a   McCurrach, Mila E ^b   Lowe, Scott W ^b   Jacks, Tyler ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

Author keywords

Apoptosis; MEFs; p53; PERP; PMP 22 gas3

Indexed keywords

PROTEIN P53;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; GENE ACTIVATION; GENE EXPRESSION; GENE INDUCTION; GENE ISOLATION; GENE SEQUENCE; HEREDITARY MOTOR SENSORY NEUROPATHY; NEUROPATHY; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; BASE SEQUENCE; CARRIER PROTEINS; CELL CYCLE PROTEINS; CELL LINE; DNA, COMPLEMENTARY; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; HUMANS; MEMBRANE PROTEINS; MICE; MOLECULAR SEQUENCE DATA; MYELIN PROTEINS; PROMOTER REGIONS (GENETICS); SEQUENCE HOMOLOGY, AMINO ACID; TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

ADENOVIRIDAE;

EID: 0034654623     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Attardi, L.D., S.W. Lowe, J. Brugarolas, and T. Jacks. 1996. Transcriptional activation by p53, but not induction of the p21 gene, is essential for oncogene-mediated apoptosis. EMBO J. 15: 3693-3701.
2. Attardi, L.D. and T. Jacks. 1999. The role of p53 in tumour suppression lessons from mouse models. Cell. Mol. Life Sci. 55: 48-63.
3. ARF links the tumour suppressors RB and p53. Nature 395: 124-125.
4. Brancolini, C., S. Marzinotto, P. Edomi, E. Agostoni, C. Fiorentini, H.W. Muller, and C. Schneider. 1999. Rho-dependent regulation of cell spreading by the tetraspan membrane protein Gas 3/PMP22. Mol. Biol. Cell 10: 2441-2459.
5. Brugarolas, J., C. Chandrasekaran, J.I. Gordon, D. Beach, T. Jacks, and G.H. Hannon. 1995. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377: 552-557.
6. Buckbinder, L., R. Talbott, S. Velasco-Miguel, I. Takenaka, B. Faha, B.R. Seizinger, and N. Kley. 1995. Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 377: 646-649.
7. Caelles, C., A. Helmberg, and M. Karin. 1994. p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature 370: 220-223.
8. ARF tumor suppressor. Genes & Dev. 12: 2434-2442.
9. Debbas, M. and E. White. 1993. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes & Dev. 7: 546-554.
10. CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82: 675-684.
11. El-Deiry, W.S. 1998. Regulation of p53 downstream genes. Semin. Cancer Biol. 8: 345-357.
12. El-Deiry, W.S., T. Tokino, V.E. Velculescu, D.B. Levy, R. Parsons, J.M. Trent, D. Lin, W.E. Mercer, K. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825.
13. Fabretti, E., P. Edomi, C. Brancolini, and C. Schneider. 1995. Apoptotic phenotype induced by overexpression of wild-type gas3/PMP22: Its relation to the demyelinating peripheral neuropathy CMT1A. Genes & Dev. 9: 1846-1856.
14. Fearnhead, H.O., J. Rodriguez, E.E. Govek, W. Guo, R. Kobayashi, G. Hannon, and Y.A. Lazebnik. 1998. Oncogene-dependent apoptosis is mediated by caspase-9. Proc. Natl. Acad. Sci. 95: 13664-13669.
15. Foulkes, W.D., J. Ragoussis, G.W. Stamp, G.J. Allan, and J. Trowsdale. 1993. Frequent loss of heterozygosity on chromosome 6 in human ovarian carcinoma. Br. J. Cancer 67: 551-559.
16. Giaccia, A.J. and M.B. Kastan. 1999. The complexity of p53 modulation: Emerging patterns from divergent signals. Genes & Dev. 12: 2973-2983.
17. Graeber, T.G., C. Osmanian, T. Jacks, D.E. Housman, C.J. Koch, S.W. Lowe, and A.J. Giaccia. 1996. Hypoxia mediated selection of cells with diminished apoptotic potential in solid tumors. Nature 379: 88-91.
18. Haupt, Y., S. Rowan, E. Shaulian, K.H. Vousden, and M. Oren. 1995. Induction of apoptosis in HeLa cells by trans-activation-deficient p53. Genes & Dev. 9: 2170-2183.
19. Hermeking, H. and D. Eick. 1994. Mediation of c-myc-induced apoptosis by p53. Science 265: 2091-2093.
20. Hurford, R.K., D. Cobrinik, M. Lee, and N. Dyson. 1997. pRB and p107/p130 are required for the regulated expression of different sets of E2F responsive genes. Genes & Dev. 11: 1447-1463.
21. Juin, P., A.O. Hueber, T. Littlewood, and G. Evan. 1999. c-Myc-induced sensitization to apoptosis is mediated through cytochrome C release. Genes & Dev. 13: 1367-1381.
22. Kastan, M., Q. Zhan, W.S. El-Deiry, F. Carrier, T. Jacks, W.V. Walsh, B.S. Plunkett, B. Vogelstein, and A.J. Fornace, Jr. 1992. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71: 587-597.
23. Knudson, C.M., K.S.K. Tung, W.G. Tourtellotte, G.A.J. Brown, and S.J. Korsmeyer. 1995. Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science 270: 96-99.
24. Lanni, J.S., S.W. Lowe, E.J. Licitra, J.O. Liu, and T. Jacks. 1997. p53-independent apoptosis induced by paclitaxel through an indirect mechanism. Proc. Natl. Acad. Sci. 94: 9679-9683.
25. Levine, A.J. 1997. p53, the cellular gatekeeper for growth and division. Cell 88: 323-331.
26. Lowe, S.W. 1995. Cancer therapy and p53. Curr. Opin. Oncol. 7: 547-553.
27. Lowe, S.W. and H.E. Ruley. 1993. Stabilization of the p53 tumor suppressor is induced by adenovirus-5 E1A and accompanies apoptosis. Genes & Dev. 7: 535-545.
28. Lowe, S.M., H.E. Ruley, T. Jacks, and D.E. Housman. 1993. p53-dependent apoptosis modulates the cytotoxicity of anti-cancer agents. Cell 74: 957-967.
29. Lowe, S.W., S. Bodis, A. McClatchey, L. Remington, H.E. Ruley, D.E. Fisher, D.E. Housman, and T. Jacks. 1994. p53 status and the efficacy of cancer therapy in vivo. Science 266: 807-810.
30. Macleod, K., N. Sherry, G. Hannon, D. Beach, T. Tokino, K. Kinzler, B. Vogelstein, and T. Jacks. 1995. p53-dependent and independent expression of p21, during cell growth, differentiation and DNA damage. Genes & Dev. 9: 935-944.
31. Malkin, D., F.P. Li, L.C. Strong, J.F.J. Fraumeni, C.E. Nelson, and D.H. Kim. 1990. Germline p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250: 1233-1238.
32. Mazurenko, N., M. Attaleb, T. Gritsko, L. Semjonova, L. Pavlova, O. Sakharova, and F. Kisseljov. 1999. High resolution mapping of chromosome 6 deletions in cervical cancer. Oncol. Rep. 6: 859-863.
33. McCurrach, M.E., T.M.F. Connor, C.M. Knudson, S.J. Korsmeyer, and S.W. Lowe. 1997. Bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis. Proc. Natl. Acad. Sci. 94: 2345-2349.
34. Millikin, D., E. Meese, B. Vogelstein, C. Witkowski, and J. Trent. 1991. Loss of heterozygosity for loci on the long arm of chromosome 6 in human malignant melanoma. Cancer Res. 51: 5449-5453.
35. Miyashita, T. and J.C. Reed. 1995. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80: 293-299.
36. Murphy, M., A. Hinman, and A.J. Levine. 1996. Wild-type p53 negatively regulates the expression of a microtubule-associated protein. Genes & Dev. 10: 2971-2980.
37. Naef, R. and U. Suter. 1999. Many facets of the peripheral myelin protein PMP22 in myelination and disease. Micr. Res. Tech. 41: 359-371.
38. Noviello, C., F. Coujal, and C. Theillet. 1996. Loss of heterozygosity on the long arm of chromosome 6 in breast cancer: Possibly four regions of deletion. Clin. Cancer Res. 2: 1601-1606.
39. O'Connor, L. and A. Strasser. 1999. Fas, p53, and apoptosis. Science 284: 1431b (in Technical Comments).
40. Okamoto, K. and D. Beach. 1994. Cyclin G is a transcriptional target of the tumor suppressor protein p53. EMBO J. 13: 4816-4823.
41. Oltvai, Z.N., C.L. Milliman, and S.J. Korsmeyer. 1993. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerated programmed cell death. Cell 74: 609-619.
42. Owen-Scaub, L.B., W. Zhang, J.C. Cusack, L.S. Angelo, S.M. Santee, T. Fujiwara, J.A. Roth, A.B. Deisseroth, W.-W. Zhang, E. Kruzel, and R. Radinsky. 1995. Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol. Cell. Biol. 15: 3032-3040.
43. Polyak, K., Y. Xia, J.L. Zweier, K.W. Kinzler, and B. Vogelstein. 1997. A model for p53-induced apoptosis. Nature 389: 300-305.
44. Qin, X.Q., D.M. Livingston, W. Kaelin, Jr., and P.D. Adams. 1994. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. 91: 10918-10922.
45. Ryan, K.M. and K.H. Vousden. 1998. Characterisation of structural p53 mutants which show selective defects in apoptosis but not cell cycle arrest. Mol. Cell. Biol. 18: 3692-3698.
46. Sabbatini, P., J. Lin, A.J. Levine, and E. White. 1995. Essential role for p53-mediated transcription in E1A-induced apoptosis. Genes & Dev. 9: 2184-2192.
47. Sakamuro, D., P. Sabbatini, E. White, and G.C. Prendergast. 1997. The polyproline region of p53 is required to activate apoptosis but not growth arrest. Oncogene 15: 887-898.
48. Scherer, S.S. and P.F. Chancer. 1995. Myelin genes: Getting the dosage right. Nat. Genet. 11: 226-228.
49. Schneider, C., R.M. King, and L. Philipson. 1988. Genes specifically expressed at growth arrest of mammalian cells. Cell 54: 787-793.
50. Sherr, C.J. 1998. Tumor surveillance via the ARF-p53 pathway. Genes & Dev. 12: 2984-2991.
51. Soengas, M., R.M. Alarcon, H. Yoshida, A.J. Giaccia, R. Hakem, T.W. Mak, and S.W. Lowe. 1999. Apaf-1 and Caspase-9 in p53-dependent apoptosis and tumor inhibition. Science 284: 156-159.
52. Spreyer, P., G. Kuhn, C.O. Hanemann, C. Gillen, H. Schaal, R. Kuhn, G. Lemke, and H.W. Muller. 1991. Axon-regulated expression of a Schwann cell transcript that is homologous to a 'growth arrest-specific' gene. EMBO J. 10: 3661-3668.
53. Symonds, H., L. Krall, L. Remington, M. Saenz-Robles, S. Lowe, T. Jacks, and T. Van Dyke. 1994. p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell 78: 703-711.
54. Wagner, A.J., J.M. Kokontis, and N. Hay. 1994. Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21 waf1/ cip1. Genes & Dev. 8: 2817-2830.
55. Welcher, A.A., U. Suter, M. De Leon, G. Jackson Snipes, and E.M. Shooter. 1991. A myelin protein is encoded by the homologue of a growth arrest-specific gene. Proc. Natl. Acad. Sci. 88: 7195-7199.
56. Wu, G.S., T.F. Burns, E.R. McDonald III, W. Jiang, R. Meng, I.D. Krantz, G. Kao, D.D. Gan, J.Y. Zhou, R. Muschel, S.R. Hamilton, N.B. Spinner, S. Markowitz, G. Wu, and W. El-Deiry. 1997. KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nat. Genet. 17: 141-143.
57. Wu, X. and A.J. Levine. 1994. p53 and E2F-1 cooperate to mediate apoptosis. Proc. Natl. Acad. Sci. 91: 3802-3806.
58. Yin, C., C.M. Knudson, S.J. Korsmeyer, and T. Van Dyke. 1997. Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature 385: 637-640.
59. Yonish-Rouach, E. 1996. Transcriptional activation plays a role in the induction of apoptosis by transiently transfected wild-type p53. Oncogene 12: 2197-2205.
60. Zindy, F., C.M. Eischen, D.H. Randle, T. Kamijo, J.L. Cleveland, C.J. Sherr, and M.F. Roussel. 1998. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes & Dev. 12: 2424-2433.
61. Zoidl, G., S. Blass-Kampmann, D. D'Urso, C. Schmalenbach, and H.W. Muller. 1995. Retroviral-mediated gene transfer of the peripheral myelin protein PMP-22 in Schwann cells: Modulation of cell growth. EMBO J. 14: 1122-1128.
62. Trembler on cell growth of NIH3T3 fibroblasts. Cell Tissue Res. 287: 459-470.